CDEK
← All drugs Report issue

golidocitinib

Small moleculeexperimental

Clinical trial activity

22 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
10
Phase 2
21
Phase 3
1
Phase 4
0

Earliest trial started Aug 3, 2023 (NCT05963347)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1
Mol. weight
489.58 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07303881Phase 2Feb 28, 2026Guangzhou Medical University
NCT07279584Phase 2Dec 20, 2025Jiao Tong University
NCT07297550Phase 1/Phase 2 (Phase 2)Dec 15, 2025China Academy of Chinese Medical Sciences
NCT07209163Phase 1/Phase 2 (Phase 2)Oct 31, 2025Jiao Tong University
NCT07196163Phase 1/Phase 2 (Phase 2)Oct 30, 2025Peking University
NCT07110103Phase 2Aug 15, 2025Chinese Academy of Medical Sciences, Dizal (Jiangsu) Pharmaceutical Co., Ltd.
NCT07093710Phase 1/Phase 2 (Phase 2)Aug 1, 2025Sun Yat-Sen University
NCT07032532Phase 2Jul 31, 2025Sun Yat-Sen University
NCT07081607Phase 2Jul 15, 2025Jiao Tong University
NCT06966154Phase 1/Phase 2 (Phase 2)May 26, 2025Fudan University
NCT06969612Phase 1May 15, 2025Peking University
NCT06630091Phase 2Mar 28, 2025University of Texas at Houston
NCT06855823Phase 1/Phase 2 (Phase 2)Jan 14, 2025Sun Yat-Sen University
NCT06733051Phase 2Dec 31, 2024Sun Yat-Sen University
NCT06757387Phase 1/Phase 2 (Phase 2)Dec 30, 2024Peking University
NCT06690671Phase 1/Phase 2 (Phase 2)Dec 15, 2024Jiao Tong University
NCT06701344Phase 2Dec 4, 2024Jiao Tong University
NCT06739265Phase 1/Phase 2 (Phase 2)Sep 1, 2024Chinese Academy of Medical Sciences
NCT06573138Phase 2Sep 1, 2024Jiao Tong University
NCT07234162Phase 3May 13, 2024Dizal (Jiangsu) Pharmaceutical Co., Ltd., Jiao Tong University
Showing 20 of 22 trials
Page 1 / 2

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jiao Tong UniversityAcademic/Hospital7622024
Sun Yat-Sen UniversityAcademic/Hospital4412024
Chinese Academy of Medical SciencesAcademic/Hospital3312024
Dizal (Jiangsu) Pharmaceutical Co., Ltd.For profit3122024
Peking UniversityAcademic/Hospital3322024
China Academy of Chinese Medical SciencesAcademic/Hospital1112025
Fudan UniversityAcademic/Hospital1112025
Guangzhou Medical UniversityAcademic/Hospital1112026
Henan Medical UniversityAcademic/Hospital1112023
University of Texas at HoustonAcademic/Hospital1112025
10 organizations
Page 1 / 1